The National Advisory Committee on Immunization (NACI) says mRNA COVID-19 vaccines are safe to use as a second dose option for Canadians who received the Oxford-AstraZeneca COVID-19 vaccine as their first. That gives provinces the green light to use the mix-and-match vaccine approach, which some have already adopted. Abigail Bimman explains the evidence behind NACI’s decision, and how it will impact Canada’s rollout.
- COVID-19: Mayors of hot spot Peel Region want shorter dose interval for AstraZeneca recipients
- Ontario residents who got AstraZeneca shot can now choose another brand for 2nd dose
- Canada’s daily COVID-19 cases plummet below 2,000 for 1st time since October